Flow Neuroscience
Generated by Meeveem AI
"First FDA approved at-home brain stimulation treatment for depression"
Malmö
•11 - 50 Employees
•Medical Devices
About Flow Neuroscience
Flow Neuroscience develops a medically approved brain stimulation headset and therapy app for treating Major Depressive Disorder at home. The tDCS device delivers gentle electrical stimulation to areas of the brain that regulate mood, combined with an app-based behavioural therapy program. Used by the NHS and backed by over 20 clinical trials, Flow offers a medication-free alternative for depression. The treatment targets reduced brain activity linked to depression, helping to rebalance neural pathways. Over 50,000 people have used Flow, with 77% reporting improvement within three weeks. FDA approved in 2025 as the first at-home tDCS treatment for moderate to severe depression, it works standalone or alongside antidepressants.
41
Team Members
2016
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where effective, accessible mental health treatment empowers everyone experiencing depression to reclaim their wellbeing without barriers of cost, stigma or medication dependency.
Our Mission
Flow Neuroscience develops new ways to combat mental health issues with science and technology.